Cargando…
Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives
Acute myeloid leukaemia (AML) is an aggressive disease of the bone marrow with a poor prognosis. Evidence suggests long established chemotherapeutic regimens used to treat AML are reaching the limits of their efficacy, necessitating the urgent development of novel targeted therapies. Canonical Wnt s...
Autores principales: | Wagstaff, Megan, Coke, Brandon, Hodgkiss, Georgia R., Morgan, Rhys G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069440/ https://www.ncbi.nlm.nih.gov/pubmed/35352805 http://dx.doi.org/10.1042/BSR20211841 |
Ejemplares similares
-
Clinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future
por: Bashir, Khawaja Muhammad Imran, et al.
Publicado: (2017) -
Pediatric Acute Myeloid Leukemia—Past, Present, and Future
por: Reinhardt, Dirk, et al.
Publicado: (2022) -
Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma
por: Zhang, Guo-Feng, et al.
Publicado: (2020) -
Crosstalk between b-catenin and WT1 signaling activity in acute myeloid leukemia
por: Wagstaff, Megan, et al.
Publicado: (2022) -
Predictive value of β-catenin in bladder cancer: a systematic review and meta-analysis
por: Ren, Jin, et al.
Publicado: (2020)